Multiple myeloma (MM) is a monoclonal gammopathy characterized by biological
heterogeneity and unregulated proliferation of plasma cells (PCs) in bone marrow (BM). MM …

Positron emission tomography (PET) is an imaging modality used for the noninvasive
assessment of tumor staging and response to therapy. PET with 18F labeled …

Multiple myeloma (MM) remains an incurable hematological neoplasm. Neoantigen-specific
T cell receptor (TCR)-engineered T (TCR-T) cell therapy is a potential alternative treatment …

Antibody-based immunotherapies have revolutionized leukemia and lymphoma treatment,
with animal studies being crucial in evaluating effectiveness and side effects. By targeting …

Simple Summary Multiple myeloma is a plasma cell cancer with bone destruction and is still
considered an incurable disease despite advancements in its treatment. Over 90% of …

Amino acid metabolic remodeling is a hallmark of cancer, driving an increased nutritional
demand for amino acids. Amino acids are pivotal for energetic regulation, biosynthetic …

Simple Summary Multiple myeloma is a plasma cell cancer involving bone destruction and
is considered an incurable disease despite significant improvements in therapeutic …

Multiple myeloma (MM) is a plasma cell malignancy that causes an accumulation of
terminally differentiated monoclonal plasma cells in the bone marrow, accompanied by …